The CE-IVD marked AltoStar® SARS-CoV-2 RT-PCR Kit 1.5 completes the altona Diagnostics test kit portfolio for the detection of SARS-CoV-2 specific RNA.

The AltoStar® Norovirus RT-PCR Kit 1.5 is an automated in vitro diagnostic test, based on real-time PCR technology, for the qualitative detection and differentiation of norovirus genogroup I (GI) and II (GII) specific RNA in human stool samples.

For your last order this year: please note information regarding the order deadline in 2020.

SARS-CoV-2, Influenza viruses and RSV cause respiratory tract infections, with very similar symptoms such as fever, cough and headache. A differential diagnosis only based on symptoms is often not possible.

On November 6, 2020, Senator Michael Westhagemann (Head of the State Ministry for Economic and Innovation) visited the diagnostic company.

The newly launched AltoStar® Influenza Screen & Type RT-PCR Kit 1.5 enables the fast and reliable detection and differentiation of the currently known subtypes and strains of globally spread influenza viruses.